Bitget App
Aqlliroq savdo qiling
Kripto sotib olishBozorlarSavdoFyuchersEarnKvadratKo'proq

HKEX:2575 stock price forecast

How will HKEX:2575 stock perform in 2026 and 2030?

This page primarily displays the projected price range for HKEX:2575 stock over the next 12 months, as well as trading recommendations for the next three months. This data is based on the historical performance of HKEX:2575, the development trends of Xuanzhu Biopharmaceutical Co., Ltd. Class H, and a summary of analysis reports from major international investment banks and Wall Street research institutions, along with price analyses and forecasts from well-known analysts on platforms such as TradingView and Reddit. Together, these sources form a comprehensive market outlook for HKEX:2575. The forecast includes potential high, median, and low price scenarios to help users understand possible future price movements across different time horizons.

This page combines Xuanzhu Biopharmaceutical Co., Ltd. Class H's financial performance and industry trends to provide short-term price predictions for HKEX:2575 stock over the next one to two years, as well as long-term price predictions extending to 2030.

The data is updated regularly as new market information becomes available. The information on this page is for reference only and does not constitute investment advice.

1-year HKEX:2575 stock price forecast

Price target:
120.29 HKD
+88.39%
Based on 1-year price forecasts from 70 analysts, the highest estimate is 156.05 HKD, while the lowest estimate is 73.45 HKD.

Analyst rating for HKEX:2575

Based on ratings from 66 analysts over the past three months, the overall consensus is Buy.

Strong buy
42
Buy
1
Hold
0
Sell
4
Strong sell
19

Tez-tez beriladigan savollar

How has HKEX:2575's EPS performed recently?

HKEX:2575's EPS is projected to reach -- HKD next quarter. Explore more Xuanzhu Biopharmaceutical Co., Ltd. Class H financial data and stay up to date on the company's latest developments on the HKEX:2575 stock details page.

What is the revenue forecast for HKEX:2575 next quarter?

Xuanzhu Biopharmaceutical Co., Ltd. Class H's revenue is projected to reach -- HKD in the next quarter. You can view Xuanzhu Biopharmaceutical Co., Ltd. Class H's revenue and earnings on the HKEX:2575 stock details page.

What is the price target for HKEX:2575?

Based on analyst estimates, the most likely target price for HKEX:2575 over the next 12 months is 120.29 HKD, with a projected high of 156.05 HKD and a projected low of 73.45 HKD. To track whether this target is reached within the next year, you can view the HKEX:2575 stock price chart on the HKEX:2575 stock details page to check the current HKEX:2575 stock price, or follow the latest developments related to HKEX:2575 on the HKEX:2575 Stock News page.

What is the analyst rating for HKEX:2575?

We collected ratings from 66 analysts who have evaluated HKEX:2575 stock over the past three months. Most analysts maintain a Buy outlook, and after aggregating all opinions, the overall consensus rating is Buy. Please note that this information does not constitute trading advice. You should still conduct your own research.

What is the projected price of HKEX:2575 stock in 2030?

Based on price forecasts and analyses of Xuanzhu Biopharmaceutical Co., Ltd. Class H from Wall Street analysts and major investment banks, HKEX:2575 is projected to trade between 127.70 HKD and 638.50 HKD in 2030.

HKEX:2575 aksiya narxining o'zgarishi

Oxirgi savdo kunida, HKEX:2575 aksiya 63.85 HKD narxda yopildi, kun uchun narx o'zgarishi 1.03%.

Aksiya fyucherslari savdosiHKEX:2575 stock details

Bitget haqida

Dunyodagi birinchi universal birja (UEX) bo'lib, u foydalanuvchilarga nafaqat kriptovalyutalar, balki aksiyalar, ETF, valyutalar, oltin va real aktivlar (RWA) bilan ham savdo qilish imkonini beradi.
Batafsil
HKEX/
HKEX:2575 stock price forecast